In vitro and in vivo studies also showed that CYP24A1 has been deemed as a candidate oncogene in many cancers, such as ovarian cancer (35), colorectal cancer (36, 37), prostate cancer (38), lung cancer (39), breast cancer (40), thyroid cancer (41), and so on. Here, CYP24A1 is linked to Familial prostate cancer.